Antisera. Lyt-l.2, Lyt-2.2, and Ly-5.1 antisera, prepared as described elsewhere (26, 27) , were kindly donated by Dr. F.-W. Shen MemoriaI-Sloan Kettering Cancer Center, New York; monoclonal (mc) anti-Thy-1-2 by Dr. Ed Clark, University of Washington, Seattle, Wash., and mc-anti Ly-1 and mc-anti Lyt-2 by Dr. J. Ledbetter and Dr. L. Herzenberg, Stanford University School of Medicine, Stanford, Calif. Expression of surface glycoproteins by each clone was determined by immunofluorescence using both mc antibodies and antisera as described previously (25, 28) .
Antigens and Immunization. SRBC, horse erythrocytes (HRBC), and burro erythrocytes (BRBC) were purchased from Colorado Serum Co., Denver, Colo. Mice were immunized i.v. with 2 × 10 a erythroeytes in 0.25 ml balanced salt solution 1-3 wk before use. Glycophorin from SRBC and HRBC (>60% homogeneous) were obtained by eluting the corresponding bands from sodium dodecyl sulfate (SDS) polyarcylamide gels of ethanol-extracted erythrocyte membranes. The asialo form of sheep glycophorin was obtained by neuraminidase treatment of the eluted glycophorin. CH-2 peptide, (>80% homogeneous) corresponding to the N-terminal region of sheep glycophorin, was obtained after chymotryptic digestion of SRBC and purified as described elsewhere (29) . Human erythrocyte glycophorin as well as its N-terminal tryptic peptide, T-2, (amino acids 1-33) were purified to virtual homogeneity as described previously (29, 30) .
Preparation of Lymphoid Cell Populations
Ly-l+2 -CELLS. Spleen cells from erythrocyte-immune donors were passed through nylonwool columns according to the method of Julius et al. (31) . Ig-, Ly-l÷2 -cells were positively selected from this cell population as follows 02, 33): Fisher petri dishes (Fisher Scientific Co., Pittsburgh, Pa.) were incubated with mc-anti-Ly-1 (12/xg/dish) and goat Ig (640/~g/dish) in 10 ml for 12 h before extensive washing with phosphate-buffered saline (PBS)-2% fetal calf serum (FCS); 5 ml of column-passed cells (107/ml) were incubated in these dishes for 60 min at 4°C with occasional shaking. After removal of nonadherent cells by swirling the plate gently, 10 ml RPMI-1640 supplemented with 10% FCS was added and the plates were slowly rocked for an additional 30 rain at 37°(. After gentle ~ipetting, eluted cells were washed twice and incubated with anti-Lyt-2.2 and Lyt-3.2 (3 × 10 cells/ml; final concentration of anti-Lyt sera: 1:30) followed by incubation for 40 rain at 37°C with selected rabbit serum as a source of complement. This procedure resulted in a cell population -->98% Lyt-l+2 -, Ig-according to immunofluorescence using either mc-anti-Ly antibodies or conventional anti-Ly sera.
B CELLS. After positive selection of cells on anti-Fab-coated plates (33) , eluted cells were incubated with me-anti-Thy-l.2 (final dilution: 1:1,000), anti-Lyt-l.2, and anti-Lyt-2.2 (final dilution of each: 1:30) for 35 min on ice, washed, and incubated an additional 30 min with rabbit complement. Lack of residual T cells was verified by immunofluorescence_using mcanti-Thy-1 antibody, as well as by the absence of anti-SRBC plaque-forming cell (PFC) responses after in vitro stimulation by SRBC.
Biological Assays for Suppressive Activity. The ability of supernates of cloned T cell populations to inhibit in vitro ~eneration of anti-SRBC PFC was determined by adding supernate material • 10 B cells from nonimmune to mixtures of 10 Ly-1 cells from SRBC-immune donors and donors in a final vol of 0.2 ml. These cell cultures were stimulated with 10 s SRBC for 5 d before anti-SRBC PFC were enumerated (34) . Inhibition of anti-SRBC helper function was tested by preincubating 105 Ly-1 cells from SRBC-immune donors (obtained as described above) with different superuate preparations for 24-36 h. Cells were then washed three times with PBS-2% FCS, counted and tested for SRBC-specific helper function after addition to cultures containing l0 s B cells and SRBC. In all cases, anti-erythrocyte PFC and total PFC were determined from triplicate euhures (35) (36) (37) .
Generation of Cl.Ly23/4 Cells. T cells from the B6 mice immunized with SRBC were treated with anti-Lyt-1.2 and complement twice before incubation in plastic dishes coated with sheep glycophorin (10 #g/dish). Adherent cells were released by vigorous pipetting, distributed into microwells (Falcon 3040 microtiter plates; Falcon Labware, Div. Becton, Dickinson & Co., Oxnard, Calif.), and expanded using culture conditions that have been described elsewhere (25) . The CI.Ly23/4 line was derived from a colony that arose in wells seeded with 1-10 cells; after 2 mo of growth, the clone was derived by micromanipulation of a single cell (25) .
Binding of Soluble Antigen to Cloned Cell Populations. Cloned cell populations were washed three times in PBS-2% FCS and resuspended at 5 X 105 cells/ml in the same medium. After incubation with various radiolabeled antigens at 4°C for 1 h, the cells were washed five times Ifi:PBS-2% FCS and radioactivity in the cell pellet was determined.
'; l~ternal Labeling of Cloned Cells. Production of labeled supernatant material from cloned cells Was carried out in serum-free conditions as follows: cells from continuously growing T cell ClSties were washed three times and incubated at l0 s cell/ml in methionine-and glutamine-free RPMI-1640 medium that was supplemented with 2 mM glutamine, 5/~g/ml human transferrin, 5/~g/ml bovine insulin, 20 U/ml aprotinin and 100-200 #Ci [SSS]methionine (1,000 Ci/mmol). After 4 h at 37°C, unlabeled methionine was added to bring the final concentration of mi~thionine to 1 mM. Cells were pelleted by centrifugation, washed repeatedly with PBS, and :st~red at -70°C for further use. 0.1 mg/ml ovalbumin was added to the supernate as carrier prbtein before centrifugation at high speed (100,000 g for 1 h) before use. . Bmdmg of S-labeled Supernatant Mater~al to Eo~throcytes. SRBC, HRBC, or BRBC (107/ml) w~re incubated with supernatant material from different T cell clones for 2 h at 4°C. The cells ygare pelleted by centrifugation (1,000 g), washed twice with PBS, and when relevant, dissolved in. Laemmli sample buffer (38) for subsequent analysis on polyacrylamide gels or scintillation counting.
• ~Affinity Chromatography of Clone Cl.Ly23/4 Supernate. Different glycophorins were conjugated t0'Sepharose 4B with cyanogen bromide (2 mg protein/ml beads) (39) . Cell supernate material ~r serum-free media (see above) was mixed with the immunoadsorbent beads (0.1 ml beads/ml supgrnate) in 5-ml syringe columns before incubation for 2 h at 4°C with occasional shaking. The eolumns were then extensively washed with PBS, followed by elution with Sorensen's glyeine-HCl (pH 2.4) buffer and immediate neutralization with excess Tris-HCl (2 M, pH 7.2). ~r,he suppressive activity of eluted cell supernatant material was always compared with the effects of serum-free media that had been eluted under identical conditions (buffer control). '~/Polyacrylamide Gel Electrophoresis. Unless otherwise indicated, eleetrophoresis was carried out irL0.7-mM thick slab gels using a modification of the method of Laemmli (38) . Briefly, 25-/~1 aikl~uots of the samples for analysis were mixed with an equal volume of a solution containing 160 mM Tris-HCl, pH 6.8; 20% glycerol; 4% SDS; 0.4% bromophenol blue; and the material was boiled for 5 min. When reducing conditions were desired, 200 mM dithiothreitol was ~dded. Gels containing 12.5% acrylamide and 0.1% SDS were subjected to electrophoresis at i20V constant voltage until the tracking dye reached the bottom of the gel. The gels were stained with Coomasie Blue and destained with 25% isopropanol-10% acetic acid solution. The me~hod of fluorographic treatment of Laskey and Mills (40) was routinely used to enhance gel Sensitivity and to reduce exposure time before drying. Radioautographs obtained using Kodak i X~-Omat XR-5 films (Eastman Kodak Co., Rochester, N. Y.) were scanned in a Joyce-Loebl :densitometer (Joyce, Loebl and Co., Gateshead-on-Tyne England). The cell surface phenotype of CI.Ly23/4 cells (determined by immunofluorescence) is Thy-I +, Lyto2 +, Ly-5 +, Ig-, NK-1-and this phenotype has been stable for >12 mo of in vitro growth. Samples of these cloned cells are routinely frozen for storage; cells are grown from thawed samples to >10 s without detectable change in surface phenotype, function, or pattern of polypeptide synthesis (25) . Expression of Ly-1 is ambiguous: indirect immunofluorescence generally indicated that a portion of cells (10-30%) emitted fluorescence slightly above background levels on the fluorescenceactivated cell sorter (FACS). (Fig. 1) . Cells from the CI.Ly23/4 clone were tested for binding to lzSI-labeled chymotryptic peptide (CH2) that corresponds to the N-terminal or external portion of SRBC glycophorin (30) . CI.Ly23/4 cells bound the CH2 peptide from SRBC glycophorin but did not bind the N-terminal portion of glycophorin from human erythrocytes (T-2) (Fig. 1A) . Other cloned T-cell populations did not bind either material (data not shown). Specificity of binding was verified by competition with different unlabeled glycophorins; excess intact cold glycophorin from sheep erythrocytes but not from erythrocytes of other species inhibited binding ( Fig. 1 B) .
Clone Cl.Ly23/4 Expresses Receptors for SRBC Glycophorin

Demonstration of Antigen-binding Peptides in Supernates of Cl.Ly23/ 4 Cultures (Tables I and H and Fig. 2). Cloned cells were pulsed with [~S]methionine for 4 h in serum-free media (Materials and Methods).
After eentrifugation (100,000 g), the supernate was incubated with different erythrocytes, (107/1 ml for 2 h at 4°C). 4-8% of total cpm present in the supernate of CI.Ly23/4 cells bound to SRBC; <2% bound to HRBC or BRBC. Other cloned cell populations from SRBC-immune donors that expressed different cell surface phenotypes (Thy-1 +, Ly-1 +2-; Thy-1 +, Ly-1-2-, NK-1 +) did not release antigen-specific binding proteins into the medium under the same conditions. Moreover, supernates from a cloned Thy-1 ÷, Ly-l-2 + cell population obtained from [ssS]Methionine internally labeled supernatant peptides (5 X 10 4 cpm) from 7 different cloned populations was incubated with 10 erythrocytes (Materials and Methods) or added to a polyvinyl plate coated with bovine serum albumin (BSA) or TNP-BSA. Although 2% of the counts per minute in supernates of CI.Ly23/4 bound to BRBC or HRBC, no discrete internally labeled peptide was detected after electrophoresis of ~5,000 cpm of BRBC or HRBC-bound material on polyacrylamide gels, in contrast to polyacrylamide gel electrophoresis of 5,000 cpm of SRBC-bound material (Fig. 2) donors immune to a different antigen 2,4,6-trinitrophenyl (TNP) bound TNP but not SRBC. (Table I) . Internally labeled supernates from C1.Ly23/4 bound to SRBC, HRBC, or human erythrocytes (5 × 103 cpm each) were analyzed by electrophoresis in SDS-polyacrylamide gels under reducing conditions. Densitometric scanning of the radioautographs of the bound material demonstrated that a major polypeptide of ~70,000 mol wt bound SRBC (Fig. 2) . No discrete polypeptide was detected in material that adhered to HRBC or human erythrocytes despite 2 wk of exposure of gels containing the same total counts per minute as SRBC-bound material.
Binding of asS-labeled supernatant material to SRBC was a result of a glycophorin recognition, because binding to 5 × 106 SRBC was inhibited by 10 #g of intact sheep glycophorin or 4 #g of the CH-2 peptide, but was not inhibited by human glycophorin (Table II) . This inhibition cannot be attributed to nonspecific properties of glycophorin molecules from sheep erythrocytes (e.g., increased hydrophobicity) because background levels of cpm bound to another erythrocyte, BRBC, were not affected by addition of SRBC glycophorin. Sugar residues present on the glycophorin molecule apparently play an important role in its antigenicity because neuraminidase treatment of sheep erythrocyte glycophorin greatly reduced its ability to inhibit binding (Table   II) . total Ig secretion as measured by a reversed PFC assay (Table III) . To determine whether antigen-binding molecules were responsible for this suppressive activity, supernates of CI.Ly23/4 cultures were applied to Sepharose 4B columns coupled with glycophorin from SRBC (SG) or human erythrocytes (HG). Suppressive activity of material retained on SG-or HG-coated columns was quantitated by adding graded amounts of the eluted protein (estimated from [aSS]-methionine content; Materials and Methods) to SRBC-stimulated cultures. As little as 1 ng of material eluted from SG-coated columns inhibited 75% of the anti-SRBC PFC response (Fig. 3) ; suppressive activity was not detectable in supernate that did not adhere to SG-coated columns. Material eluted from HG-coated columns contained suppressive activity at high concentrations (50 ng/ml) (Fig. 3) . This latter activity might be accounted for by cross-reactive binding to HG, or by nonspecific interactions with HG. We favor the latter explanation because suppressive activity retained on HG-columns but not on SG-columns could be eluted by Nonidet P-40 (NP-40) nonionic detergent (0.3%) (Fig. 4) . To determine whether suppressive activity in supernatant material that passed through HG-coated columns after washing with PBS could bind to SG, this material was reapplied to SG-coated columns (Fig. 5) . These data show that passage of CI.Ly23/4 supernate through HG-coated columns before elution from SG-coated columns resulted in approximately a 50-fold increase in specific suppressive activity/ng of protein: as little as 0.02 ng of this material inhibited 80% of the anti-SRBC PFC response. (Fig. 6) . The 
Cellular Target of Clone Cl. sly23~4 Suppressive Activity
Sequential Eluflon Buffer
Fro. 4. Effect of low concentrations of NP-40 on the retention of suppressive activity on glycophorin columns. CL.Ly23/4 supernates were applied to glycophorin columns as described in Fig. 3 . The columns were then washed sequentially with 10-ml aliquots of PBS containing increasing amounts of NP-40 (0-1%) followed by final elution with I0 ml glycine-HCl, pH 2.4, buffer. The different fractions (after dialysis against PBS) were tested for suppression of anti-SRBC PFC at a final dilution of (1:20). 
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Fraction number Fio. 7. Sephacryl S-200 column chromatography of SG-binding proteins from CI.Ly23/4 superhates. Internally labeled CI.Ly23/4 supernatant material was eluted from SG-coated columns by low pH buffer and fractionated by Sephacryl 8-200 chromatography on 100-× 2-cm columns equilibrated with PBS containing 2% glycerol, 1 mM, phenylmethylsulfonylfluoride, and 100 mM KCI. Each 2-ml fraction was tested for radioactivity and for suppression (final dilution: 1:100) of the anti-SRBC PFC resource in cultures containing SRBC and mixtures of Ly-l+2 -cells and B cells. K, 1,000 mol wt; STI, soybean trypsin inhibitor. (Fig. 7) were pooled and concentrated. Ly-l+2 -helper T cells (10 s) from either SRBC-or HRBC-immune donors were preincubated for 24 h with 0,5 ng of this material and either l0 s SRBC or HRBC before testing for helper T cell activity as indicated Fi~. 6. (Fig. 7 and Table IV ). Because suppressive activity in CI.Ly23/4 supernate was lost after passage through SG-but not HG-coated columns, we asked whether the molecular weight of suppressive material corresponded to the molecular weight of material that bound to SRBC. After Sephacryl S-200 chromatography of material eluted from SG-coated columns, suppressive activity was concentrated in a few fractions having the same molecular weight as antigen-binding material (Fig. 7, 70 ,000 tool wt).
A 70,O00-mol wt Fraction of Cl.Ly23/4 Supernate Specifically Suppresses T Helper Activity for SRBC but No Other E~ythrocytes
To determine whether suppression of Ly-1 cells by the 70,000-mol wt supernate material was SRBC specific, Ly-1 cells from donors immune to SRBC or HRBC were preincubated with the homologous erythroeyte and the 70,000-mol wt fraction obtained after elution from Sephacryl columns; this incubation diminished subsequent anti-SRBC but not anti-HRBC helper activity (Table IV) . Similarly, preincubation of Ly-1 cells from donors immune to BRBC did not inhibit subsequent anti-BRBC helper activity (data not shown).
Discussion
We have generated cloned cells bearing the Thy-1 +, Ly-l±2+3 + surface glycoprotein pattern (CI.Ly23/4). This cell line was derived by single cell micromanipulation and has been propagated in continuous culture for >12 mo. Cells of this cloned line have maintained stable expression of cell surface gene products (Ig-Ly/b2-; Thy-l+; Ly-1±2 +, Ly-3 +, Ly-5+; NK-I-, Qa-5-), and stable biologic function. Cells of this clone, in contrast to T suppressor clones that had been derived after elution from dishes coated with other antigens, bound specifically to a chymotryptic peptide (CH-2) (Fig.  1) , which represents the external portion of the SG molecule (29, 30) . Because the CH-2 peptide does not contain amino acids that span the erythrocyte membrane, it is considerably less hydrophobic than the entire molecule. Because CI.Ly23/4 cells bound the CH2 peptide at least as efficiently as the whole molecule, it is likely that binding reflects immunologic recognition of the external portion of the molecule rather than hydrophobie interactions. These data ( Fig. 1 A and B) demonstrate that cloned T cells express specific and saturable receptor activity for free antigen; we do not know whether major histocompatibility complex products also contribute to the affinity of this antigen-specific binding. Although we have not performed extensive binding studies, data obtained so far indicate that each T cell binds ~5 × 104 SG molecules. Assuming one glycophorin molecule bound per receptor, this figure is -10-fold lower than the numbers of cell-bound receptors thought to be expressed on B cells (41) .
This analysis also demonstrates that, in addition to carrying receptors for antigen at its membrane surface, CI.Ly23/4 cells produce antigen-binding polypeptides (Table  I) . Although we have not formally demonstrated that these internally labeled polypeptides are secreted, the findings that (a) virtually all antigen-binding activity is present in the supernatant fraction after centrifugation at 100,000 g (Fig. 2) and (b) very little is detectable in membrane or cytoplasmic fractions (M. Fresno, L. McVayBoudreau, and H. Cantor, manuscript in preparation) speaks against the possibility of binding by supernatant material randomly shed from the cell. Analysis of metabolically labeled material in supernates demonstrated that a molecular species having an apparent 70,000 mol wt (Fig. 2) accounted for almost all specific binding and that binding of this 70,000-mol wt material to sheep erythrocytes was completely inhibited by glycophorin-enriehed peptides from SRBC but not human erythrocytes or HRBC (Table II) .
Approximately 2-3% of internally labeled proteins synthesized by CI.Ly23/4 cells is found in the supernatant fraction and ~10% of this represents antigen-binding material. By contrast, extensive analysis of clones of prethymic cells, thymocytes, inducer celts and NK cells has shown that these cell types do not synthesize 70,000-mol wt antigen-binding polypeptides (25) . These findings suggest that synthesis and secretion of these antigen-binding 70,000-mol wt peptides is a specialized function of CI.Ly23/4 eetts.
The combined use of the sheep erythrocyte and different glycophorin molecules has allowed analysis of the fine specificity of binding by the 70,000-mol wt polypeptides. Binding to SRBC is likely to reflect recognition of glycophorin determinants because it is inhibited by low concentrations of intact molecules as well as the N-terminal portion of this molecule. The latter peptides inhibit less efficiently than the whole molecule. This may indicate the contribution of an additional sequence of the glycophorin to binding or may simply reflect differences in the conformation between the intact glycophorin and the chymoeryptic peptide. Interestingly, sialic acid residues on glycophorin molecules play a major role in its recognition by both 70,000-mol wt peptides (Table II) and the intact cells (data not shown).
It is generally accepted that suppressor effector cells express the Ly-1-23 + surface phenotype (1) (2) (3) 42) . After incubation with mc-Lyt-1 or conventional Ly-1 antisera, a portion of C1.Ly23/4 cells (~20%) are read as slightly above background in the FACS. This does not reflect the surface phenotypes of two distinct clones because CI.Ly23/4 was derived after single cell mieromanipulation and regrowth (25) . Ly-1+2 + cells in uncloned T cell populations may produce antigen-specific material (43) and have been implicated as precursors of suppressor cells (42) . Because only about one-fifth of C1.Ly23/4 cells express low amounts of Ly-1, an intriguing possibility is that cells within this clone may continuously differentiate in cell culture as follows: Ly-l+2 + (20%) ~ Ly-l-2 + (80%).
The results reported here demonstrate that internally labeled peptides from C1.Ly23/4 specifically suppress in vitro antibody responses. These suppressive peptides bind specifically to columns coated with SG (Figs. 3 and 5) and have an ~70,000 mol wt (Figs. 2 and 7) . Although small amounts of suppressive activity are detectable in material bound to columns coated with HG, this binding is sensitive to NP-40 detergent, unlike binding to columns coated with SG.
The 70,000-mol wt polypeptides described here can be classified as final mediators of T suppression because they directly inhibit helper activity of Ly-1 cells. By contrast, most products from T suppressor cells that have been studied stimulate other T cells to augment T-suppression primarily by activating Ly-l+2 ÷ cells to amplify the generation of suppression from Ly-l-2 ÷ cells (4, 5, (7) (8) (9) (10) (11) (12) .
Perhaps the most striking finding reported here is that polypeptides from a single T cell clone can completely preempt the antibody response to a foreign cell. These studies do not rule out the possibility that suppression is carried out by a family of polypeptides, and that only a small fraction of these polypeptides bind specifically to molecules on the erythrocyte surface. According to this idea, interactions among erythrocyte-specific peptides and other molecules are required to completely suppress the response to the whole erythrocyte. Alternatively, binding of a single polypeptide to a unique determinant on a foreign erythrocyte may preempt the primary antibody response to the entire cell. To distinguish between these alternatives, and to gain insight into the structural basis of specific immunologic suppression, we have examined the biologic activity of biosynthetically labeled molecules that have been purified to homogeneity. This analysis is described in the accompanying report (44) .
Summary
We have generated continuously propagatable T lymphocyte clones to study antigen-specific T cell functions. All Ly-2 + clones mediate suppressive activity and secrete a characteristic pattern of polypeptides that differs from Ly-2-T cell clones. Cells of one clone, CI.Ly23/4, specifically bind glycophorin from sheep erythrocytes (SRBC). After incubation with [~S]methionine, supemate material from this clone also contains biosynthetically labeled 70,000-mol wt proteins that specifically bind to SRBC and this binding is inhibited by glycophorin from sheep but not other erythrocytes. These antigen-binding 70,000-tool wt peptides specifically and completely suppress primary anti-SRBC responses generated by mixtures of primed Ly-1+2 -ceils and B cells. Suppression by these antigen-binding peptides reflects direct inhibition of T-helper activity.
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